| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/01/2002 | CA2431904A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 08/01/2002 | CA2429353A1 Lfa-1 antagonist compounds |
| 08/01/2002 | CA2424402A1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 07/31/2002 | EP1227093A2 Beta-lactams useful for preparation of taxanes having furyl or thienyl substituted side-chain |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226140A1 Novel indole compounds |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1226136A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226128A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226120A2 Benz[f]indoles for use in the treatment of 5ht receptor related disorders |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP0880500B1 Esters of 3-hydroxy-piperidinemethanol derivatives |
| 07/31/2002 | CN1361777A Substituted phenyl uracils |
| 07/31/2002 | CN1361776A Novel fluorinated imidazoline Benzodioxane, preparation and therapeutic uses thereof |
| 07/31/2002 | CN1361775A Novel diphenyl-piperidine derivate |
| 07/31/2002 | CN1361770A Heteroaromatic ring compounds |
| 07/31/2002 | CN1361769A Substituted 2-aryl-1,2,4-triazine-3,5-di(thi) one |
| 07/31/2002 | CN1361692A Novel use of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1088459C 1,4-disubstituted piperazines |
| 07/31/2002 | CA2369462A1 Nicotinamide acids, amides, and their mimetics active as inhibitors of pde4 isozymes |
| 07/30/2002 | US6426413 Inhibitors of caspases |
| 07/30/2002 | US6426360 Antiarthritic agents |
| 07/30/2002 | US6426354 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 07/30/2002 | US6426318 3-aryl-1,2,4-triazone derivatives with herbicidal properties |
| 07/30/2002 | CA2344707C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 07/30/2002 | CA2054342C Azolylmethylspiro [2.5] octanols and fungicides containing these |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057250A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | WO2002057249A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057248A2 Inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | WO2002057240A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | WO2002057238A1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002057224A2 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
| 07/25/2002 | WO2002056887A1 New combination of active ingredients containing alfuzosine and apomorphine |
| 07/25/2002 | WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
| 07/25/2002 | WO2002050061A8 Piperazine derivatives for treatment of bacterial infections |
| 07/25/2002 | WO2002042268A3 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 07/25/2002 | WO2002039988A3 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 07/25/2002 | WO2002038107A3 Stat modulators |
| 07/25/2002 | WO2002032874A3 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | US20020099224 Hydrolysis of [R (R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 07/25/2002 | US20020099223 Cyclocarbonylating acetic acid (or benzoic acid)-1-(1-benzenesulfonyl-1H-indol-2-yl)-allyl ester to obtain 9-benzenesulfonyl-9H-carbazol-4-yl ester; saponifying |
| 07/25/2002 | US20020099219 Piperidine compounds and process for providing the same |
| 07/25/2002 | US20020099215 For therapy and prophylaxis of P-glycoprotein-mediated multidrug resistance |
| 07/25/2002 | US20020099214 For prophylaxis and therapy of pruritus |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099205 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid |
| 07/25/2002 | US20020099202 Compoound for use in the sequencing of nucleic acids |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099084 Pharmaceutically active compounds and methods of use |
| 07/25/2002 | US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia |
| 07/25/2002 | US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine |
| 07/25/2002 | US20020099035 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 07/25/2002 | US20020099007 And the prenylation of the oncogene protein Ras; peptidomimetic macrocyclic compounds |
| 07/25/2002 | DE10130830A1 Indol-Derivate Indole derivatives |
| 07/25/2002 | CA2435117A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases |
| 07/25/2002 | CA2433835A1 Tetrahydropyran derivatives as neurokinin receptor antagonists |
| 07/25/2002 | CA2432870A1 Substituted triazole diamine derivatives as kinase inhibitors |
| 07/25/2002 | CA2425135A1 Synthesis and antimicrobial activity of novel dicationic "reversed amidines" |
| 07/24/2002 | EP1225171A1 Substituted cyanophenyluracils |
| 07/24/2002 | EP1224933A1 New combination of active ingredients containing alfuzosine and apomorphine |
| 07/24/2002 | EP1224197A1 Hygromycin derivatives |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224182A1 N-substituted 1-(lactone) isoquinolones for treating nervous disorders |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | EP1224170A1 6-position substituted indoline, production and use thereof as a medicament |
| 07/24/2002 | EP1224165A1 Novel compounds |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP0989114B1 N,n-disubstituted amic acid derivatives |
| 07/24/2002 | EP0934527B1 Non radioactive receptor assay suitable for quantitative and qualitative analysis of trace amounts of receptor binding analyte |
| 07/24/2002 | EP0889041B1 Novel iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 07/24/2002 | EP0814804B1 Substituted benzopyrans |
| 07/24/2002 | EP0804431B1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/24/2002 | EP0689463B1 Imidazole based nitrogen-sulfur ligands useful in radiographic imaging agents |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360605A Thermoplastic polymer having polar group, use thereof, and unsaturated compounds having polar group |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360576A Process for preparation of spiro [(4-cyclohexanone)-[3H] indol]-2'[iH]-one derivs. |
| 07/24/2002 | CN1359900A Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/23/2002 | US6423847 Reacting a-tocopherol with a nicotinic compound; therapy for vision disorders |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423723 Oral bioavailability |
| 07/23/2002 | US6423716 Nitrogenous heterocyclic compounds |
| 07/23/2002 | US6423713 Substituted pyrazoles as p38 kinase inhibitors |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |